Literature DB >> 22706361

[Human Papilloma Virus (HPV), cervical cancer incidence and screening uptake: differences among Northern, Central and Southern Italy].

Paolo Giorgi Rossi1, Francesco Chini, Piero Borgia, Gabriella Guasticchi, Francesca Maria Carozzi, Massimo Confortini, Claudio Angeloni, Carlotta Buzzoni, Franco Maria Buonaguro.   

Abstract

OBJECTIVE: this article presents a review of evidences about Human Papillomavirus (HPV) and cervical cancer in Italy, highlighting geographical differences.
DESIGN: two systematic reviews recently published were updated, one collecting studies on the prevalence of HPV types in Italy in the general population and the other collecting prevalence of HPV types in cervical pathologic samples.The search was updated to 31.10.2010 and performed exclusively in MedLine and references in retrieved papers. MAIN OUTCOME MEASURES: the prevalence of HPV types has been related with the incidence of cervical cancer and the spread of Pap tests and screening programs.
RESULTS: the prevalence high risk HPV types is 8%in studies with population-based random sample, with no significant difference between Centre-North and South-Islands, however, the prevalence is slightly higher in the South than the Centre-North for women up to 54 years of age, whereas in older women the ratio is reversed. HPV 16 is the most common type, while HPV 18 is less frequent, 5% and 1% respectively. The average of HPV 16 positivity is 64% and 68% in CIN2/3 and invasive cancer respectively, while the average of HPV 18 is 7% and 11% in CIN2/3 and invasive cancer respectively. There are no significant differences by geographical area.The incidence of invasive cervical cancer in Italy has been decreasing in recent years changing from 9.2 to 7.7 per 100,000 inhabitants in 10 years. The incidence is lower in South-Islands. Pap test coverage is over 80% in Centre-North and less than 60%in South-Islands.
CONCLUSIONS: cervical cancer incidence is lower in Southern Italy, while the Pap test coverage is much higher in Centre-Northern Italy. This paradox, until now, has been interpreted as a consequence of a lower HPV prevalence in Southern than Northern regions. Recent studies on HPV prevalence do not confirm this hypothesis. Our interpretation is that in Southern Italy we are facing an epidemiologic scenario in transition where the low cancer incidence is the consequence of a low HPV prevalence in the previous decades, but new generations are experiencing a higher prevalence of HPV and will probably have higher risk of cervical cancer. The consequence may be an epidemic of cervical cancer in the next decades, if adequate screening programs are not implemented.

Entities:  

Mesh:

Year:  2012        PMID: 22706361

Source DB:  PubMed          Journal:  Epidemiol Prev        ISSN: 1120-9763            Impact factor:   1.901


  9 in total

1.  Therapeutic Efficacy of a Coriolus versicolor-Based Vaginal Gel in Women with Cervical Uterine High-Risk HPV Infection: A Retrospective Observational Study.

Authors:  Anna Angela Criscuolo; Francesco Sesti; Emilio Piccione; Pasquale Mancino; Elena Belloni; Cetty Gullo; Marco Ciotti
Journal:  Adv Ther       Date:  2020-12-26       Impact factor: 3.845

Review 2.  Human papillomavirus in Ethiopia.

Authors:  Awoke Derbie; Daniel Mekonnen; Gizachew Yismaw; Fantahun Biadglegne; Xaveer Van Ostade; Tamrat Abebe
Journal:  Virusdisease       Date:  2019-04-20

Review 3.  Human papillomavirus infection by anatomical site among Greek men and women: a systematic review.

Authors:  Savas Tsikis; Lea Hoefer; Angella Charnot-Katsikas; John A Schneider
Journal:  Eur J Cancer Prev       Date:  2016-11       Impact factor: 2.497

4.  Prevalence of abnormal Pap smear results in inflammatory bowel disease: a prospective study.

Authors:  Andrea Brunner; Wolfgang Kruis; Birgid Schömig-Markiefka; Julia Morgenstern; Marianne Engels; Reinhard Büttner; Dirk Michael Forner
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-03       Impact factor: 4.322

5.  HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs.

Authors:  Cinzia Campari; Chiara Fedato; Alessio Petrelli; Manuel Zorzi; Carla Cogo; Adele Caprioglio; Federica Gallo; Livia Giordano; Serena Domenighini; Luigi Pasquale; Sonia Prandi; Marco Zappa; Paolo Giorgi Rossi
Journal:  Infect Agent Cancer       Date:  2015-05-07       Impact factor: 2.965

6.  Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter.

Authors:  P Giorgi Rossi; C Fortunato; P Barbarino; S Boveri; S Caroli; A Del Mistro; A Ferro; C Giammaria; M Manfredi; T Moretto; A Pasquini; M Sideri; M C Tufi; C Cogo; E Altobelli
Journal:  Br J Cancer       Date:  2015-01-29       Impact factor: 7.640

7.  Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer.

Authors:  Mahdieh Farzanehpour; Sayed-Hamidreza Mozhgani; Somayeh Jalilvand; Ebrahim Faghihloo; Setareh Akhavan; Vahid Salimi; Talat Mokhtari Azad
Journal:  Virol J       Date:  2019-10-07       Impact factor: 4.099

8.  HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies.

Authors:  Paolo Giorgi Rossi; Mario Sideri; Francesca Maria Carozzi; Amina Vocaturo; Franco Maria Buonaguro; Maria Lina Tornesello; Elena Burroni; Luciano Mariani; Sara Boveri; Leandra Maria Zaffina; Francesco Chini
Journal:  Infect Agent Cancer       Date:  2012-10-12       Impact factor: 2.965

9.  Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing.

Authors:  Farzane Jamdar; Farah Farzaneh; Fariba Navidpour; Sarang Younesi; Payam Balvayeh; Maryamsadat Hosseini; Robabeh Ghodssi-Ghasemabadi
Journal:  Infect Agent Cancer       Date:  2018-01-25       Impact factor: 2.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.